Salarius Pharmaceuticals
Decoy Therapeutics is a biotechnology company focused on innovative therapeutic solutions. They are engaged in scientific research and development, with a presence in Cambridge, MA, and New York, NY. The company collaborates with innovation centers and maintains a focus on advancing medical science.
Industries
Nr. of Employees
small (1-50)
Salarius Pharmaceuticals
Products
Pan-Coronavirus Broad-acting Fusion Inhibitor
A nasally inhaled antiviral designed to inhibit fusion of all known human coronaviruses, providing prophylactic protection and reducing disease severity in immunocompromised patients.
Tripledemic Broad-acting Fusion Inhibitor
An inhaled antiviral fusion inhibitor targeting influenza, COVID-19, and RSV viruses responsible for most lower respiratory tract infections.
GPCR-targeted Peptide-drug Conjugate for Colorectal Tumors
A peptide-drug conjugate targeting over-expressed G-protein Coupled Receptors in colorectal cancer cells for biomarker-driven precision therapy.
Decoy Therapeutics Peptide Conjugate Engineering Platform
An AI-driven platform for designing, synthesizing, and manufacturing peptide conjugate therapeutics with optimized drug-like properties.
Pan-Coronavirus Broad-acting Fusion Inhibitor
A nasally inhaled antiviral designed to inhibit fusion of all known human coronaviruses, providing prophylactic protection and reducing disease severity in immunocompromised patients.
Tripledemic Broad-acting Fusion Inhibitor
An inhaled antiviral fusion inhibitor targeting influenza, COVID-19, and RSV viruses responsible for most lower respiratory tract infections.
GPCR-targeted Peptide-drug Conjugate for Colorectal Tumors
A peptide-drug conjugate targeting over-expressed G-protein Coupled Receptors in colorectal cancer cells for biomarker-driven precision therapy.
Decoy Therapeutics Peptide Conjugate Engineering Platform
An AI-driven platform for designing, synthesizing, and manufacturing peptide conjugate therapeutics with optimized drug-like properties.
Services
Regulatory and clinical development consulting
Advisory services addressing clinical development plans, regulatory interactions, and drug development strategy for oncology programs.
Regulatory and clinical development consulting
Advisory services addressing clinical development plans, regulatory interactions, and drug development strategy for oncology programs.
Expertise Areas
- Clinical trial management (oncology)
- Regulatory advisory and FDA engagement
- Tertiary oncology clinical operations
- Translational oncology research
Key Technologies
- Clinical trial design and execution
- Regulatory strategy and advisory processes
- Translational oncology research and therapeutic development